Cantitate/Preț
Produs
Total produse
Vezi coșul
Nucleic Acid Therapeutics in Cancer de Alan M. Gewirtz

Nucleic Acid Therapeutics in Cancer: Cancer Drug Discovery and Development

Editat de Alan M. Gewirtz
en Limba Engleză Hardback – 25 mar 2004
A cutting-edge review of the important issues underlying the therapeutic use of nucleic acid-mediated gene silencing. Topics range from basic methodology and delivery to targeting and clinical targets. The authors thoroughly explain the latest developments in RNA biology, as well as the underpinnings of RNA interference, oligodeoxynucleotide delivery into cells, and strategies for targeting these molecules to accessible regions within the mRNA. They also provide some examples of how these new therapeutic compounds are being used clinically.
Citește tot Restrânge

Toate formatele și edițiile

Toate formatele și edițiile Preț Express
Paperback (1) 71172 lei  43-57 zile
  Humana Press Inc. – 26 iul 2012 71172 lei  43-57 zile
Hardback (1) 72780 lei  43-57 zile
  Humana Press Inc. – 25 mar 2004 72780 lei  43-57 zile

Din seria Cancer Drug Discovery and Development

  • 5% CNS Cancer: Models, Markers, Prognostic Factors, Targets, and Therapeutic Approaches
    Preț: 147498 lei
  • 5% Developments in T Cell Based Cancer Immunotherapies
    Preț: 110835 lei
  • 5% mTOR Pathway and mTOR Inhibitors in Cancer Therapy
    Preț: 141575 lei
  • 5% Antiangiogenic Agents in Cancer Therapy
    Preț: 137019 lei
  • 5% Tumor Models in Cancer Research
    Preț: 145228 lei
  • 5% Telomeres and Telomerase in Cancer
    Preț: 131674 lei
  • 5% Gene Therapy for Cancer
    Preț: 143950 lei
  • 5% Proteasome Inhibitors in Cancer Therapy
    Preț: 111363 lei
  • 5% Oncogene-Directed Therapies
    Preț: 112624 lei
  • 24% Protein Tyrosine Kinases: From Inhibitors to Useful Drugs
    Preț: 103759 lei
  • 5% Cancer Chemoprevention: Volume 2: Strategies for Cancer Chemoprevention
    Preț: 146637 lei
  • 5% Apoptosis, Senescence and Cancer
    Preț: 135078 lei
  • 5% Bioinformatics in Cancer and Cancer Therapy
    Preț: 141754 lei
  • 5% Bone Metastasis
    Preț: 111346 lei
  • 5% Nitric Oxide (NO) and Cancer: Prognosis, Prevention, and Therapy
    Preț: 142854 lei
  • 5% Tumor Suppressor Genes in Human Cancer
    Preț: 142980 lei
  • 5% Platinum-Based Drugs in Cancer Therapy
    Preț: 78210 lei
  • 5% Regional Cancer Therapy
    Preț: 143858 lei
  • 5% Checkpoint Controls and Targets in Cancer Therapy
    Preț: 111032 lei
  • 5% Antifolate Drugs in Cancer Therapy
    Preț: 143439 lei
  • 5% Transforming Growth Factor-Beta in Cancer Therapy, Volume II: Cancer Treatment and Therapy
    Preț: 136582 lei
  • 5% Transforming Growth Factor-Beta in Cancer Therapy, Volume I: Basic and Clinical Biology
    Preț: 146108 lei
  • 5% Farnesyltransferase Inhibitors in Cancer Therapy
    Preț: 110686 lei
  • 5% Supportive Care in Cancer Therapy
    Preț: 98218 lei
  • 5% Stem Cells and Cancer
    Preț: 133176 lei
  • 5% EGFR Signaling Networks in Cancer Therapy
    Preț: 129740 lei
  • 5% Hematopoietic Growth Factors in Oncology: Basic Science and Clinical Therapeutics
    Preț: 112459 lei
  • 5% Sensitization of Cancer Cells for Chemo/Immuno/Radio-therapy
    Preț: 143310 lei
  • 5% Hormone Therapy in Breast and Prostate Cancer
    Preț: 111090 lei
  • 5% Platinum and Other Heavy Metal Compounds in Cancer Chemotherapy: Molecular Mechanisms and Clinical Applications
    Preț: 131776 lei
  • 5% The Oncogenomics Handbook
    Preț: 146491 lei
  • 5% Macromolecular Anticancer Therapeutics
    Preț: 193963 lei
  • 5% Histone Deacetylases: Transcriptional Regulation and Other Cellular Functions
    Preț: 141848 lei
  • 5% Cancer Drug Resistance
    Preț: 143894 lei
  • 5% Matrix Metalloproteinase Inhibitors in Cancer Therapy
    Preț: 110030 lei
  • 5% Fluoropyrimidines in Cancer Therapy
    Preț: 110996 lei
  • 5% In Vivo Imaging of Cancer Therapy
    Preț: 99058 lei
  • 5% The Tumor Microenvironment
    Preț: 144313 lei
  • 5% Camptothecins in Cancer Therapy
    Preț: 142891 lei
  • 5% Targets for Cancer Chemotherapy: Transcription Factors and Other Nuclear Proteins
    Preț: 78758 lei
  • 5% Cancer Proteomics: From Bench to Bedside
    Preț: 131172 lei
  • 5% Genomics and Pharmacogenomics in Anticancer Drug Development and Clinical Response
    Preț: 133176 lei
  • 5% COX-2 Blockade in Cancer Prevention and Therapy
    Preț: 111311 lei
  • 5% Cytokines in the Genesis and Treatment of Cancer
    Preț: 144076 lei

Preț: 72780 lei

Preț vechi: 76610 lei
-5% Nou

Puncte Express: 1092
Preț estimativ în valută:
13927€ • 14577$ • 11591£

Carte tipărită la comandă

Livrare economică 31 martie-14 aprilie

 Adaugă în coș

Wish list
Gift list
Am citit!
Adaugă în listă
Preluare comenzi: 021 569.72.76

Specificații

ISBN-13: 9781588292582
ISBN-10: 1588292584
Pagini: 236
Ilustrații: X, 221 p. 49 illus., 5 illus. in color.
Dimensiuni: 178 x 254 x 20 mm
Greutate: 0.72 kg
Ediția:2004
Editura: Humana Press Inc.
Colecția Humana
Seria Cancer Drug Discovery and Development

Locul publicării:Totowa, NJ, United States

Public țintă

Professional/practitioner

Cuprins

I. Introduction and Perspective.- 1 Antisense Methodology: An Assessment After 25 Years.- 2 Nucleic Acid Therapeutics: An Introduction.- II. Basic Methodology.- 3 Targeted Genome Modification Via Triple Helix Formation.- 4 Therapeutic Applications of Ribozymes.- 5 Use of Catalytic DNA in Target Validation and Therapeutics.- 6 Targeted Destruction of Small, Stable RNAs: Principles Applicable to Antisense Therapies.- 7 Mechanism of Action of Antisense RNA in Eukaryotic Cells.- III. Delivery.- 8 The Transport of Oligonucleotides Into Cells.- 9 Peptide-Mediated Delivery of Antisense Oligonucleotides and Related Material.- 10 Molecular Vectors for Gene Delivery to Cancer Cells.- IV. Targeting.- 11 Considerations on the Design of Antisense Oligonucleotides.- 12 Identification of Hybridization Accessible Sequence in Messenger RNA.- V. Clinical Targets.- 13 Nucleic Acids As Gene Targeting Therapeutics.- 14 LY900003 (Isis 3521) and G3139 (Genasense; Oblimersen): Phosphorothioate Antisense Oligonucleotides With Pleiotropic Mechanisms of Action.- 15 Antisense Protein Kinase A-RI? Restores Normal Signal Transduction Signatures to Inhibit Tumor Growth.

Textul de pe ultima copertă

The development of effectively targeted and efficiently delivered nucleic acids promises important advances in the diagnosis and treatment of human malignancies. In Nucleic Acid Therapeutics in Cancer, leading researchers, academic physicians, and clinicians clearly and succinctly review the important issues underlying the therapeutic use of nucleic acid-mediated gene silencing. Topics range from basic methodology and delivery to targeting methods and specific clinical targets. The authors thoroughly explain the latest developments in RNA biology, as well as the underpinnings of RNA interference, oligodeoxynucleotide delivery into cells, and strategies for targeting these molecules to accessible regions within the mRNA. They also provide some examples of how these new therapeutic compounds are being used clinically.
Concise yet highly readable, Nucleic Acid Therapeutics in Cancer offers those who require a cutting-edge critical synthesis not only a state-of-the-art account of this promising field, but also an illuminating introduction to their emerging therapeutic uses.

Caracteristici

Includes supplementary material: sn.pub/extras